首页 | 本学科首页   官方微博 | 高级检索  
检索        


Comparative in silico analyses and experimental validation of novel splice site and missense mutations in the genes MLH1 and MSH2
Authors:Beate Betz  Stephan Theiss  Murat Aktas  Carolin Konermann  Timm O Goecke  Gabriela Möslein  Heiner Schaal  Brigitte Royer-Pokora
Institution:1. Institut fuer Humangenetik, Universitaetsklinikum Duesseldorf, Universitaetsstrasse 1, 40225, Duesseldorf, Germany
2. RESULT GmbH, Friedenstra?e 39, 40219, Duesseldorf, Germany
3. Institut fuer Transplantationsdiagnostik und Zelltherapeutika, Universitaetsklinikum Duesseldorf, Universitaetsstrasse 1, 40225, Duesseldorf, Germany
4. Institut fuer Virologie, Universitaetsklinikum Duesseldorf, Universitaetsstrasse 1, 40225, Duesseldorf, Germany
5. Klinik fuer Chirurgie, St Josefs-Hospital Bochum-Linden, 44879, Bochum, Germany
Abstract:Hereditary non-polyposis colorectal cancer, an autosomal dominant predisposition to colorectal cancer and other malignancies, is caused by inactivating mutations of DNA mismatch repair genes, mainly MLH1 and MSH2. Missense mutations affect protein structure or function, but may also cause aberrant splicing, if located within splice sites (ss) or cis-acting sequences of splicing regulatory proteins, i.e., exonic splicing enhancers or exonic splicing silencers. Despite significant progress of ss scoring algorithms, the prediction for the impact of mutations on splicing is still unsatisfactory. For this study, we assessed ten ss and nine missense mutations outside ss in MLH1 and MSH2, including eleven newly identified mutations, and experimentally analyzed their effect at the RNA level. We additionally tested and compared the reliability of several web-based programs for the prediction of splicing outcome for these mutations.
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号